| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy cannot demonstrate that it has appropriately reviewed and mitigated the risks associated with its services, in particular working with a third-party prescribing service and providing its services at a distance. |
A risk assessment will be drafted to determine the risk for the type of pharmacy services that are provide along with control measures. The risks associated with the prescribing service CMS Ltd will be assessed. Since CMS Ltd CQC registered the risk assessment will consider the GMC principals and control measures. |
11/03/2025 | 06/03/2025 |
| 4.2 | The pharmacy relies on the third-party prescribing service to make clinical checks about medicines people are prescribed. The pharmacy cannot demonstrate that there is sufficient clinical oversight of its dispensing process. So, this could increase the risk that people receive medicines which are not clinically appropriate for them. |
A review of the dispensing process will be carried out so that a clinical check can be integrated into the current work flow. Dispensary pharmacists will be given contact details of GP leads to escalate issues that may result in inappropriate supply. The management tool Jira will be used. |
11/03/2025 | 06/03/2025 |
Pharmacy inspections
Inspection reports and learning from inspections